Single-Shot Liposomal Bupivacaine Non-Inferior to Continuous Block After Knee Arthroplasty
This non-inferiority trial helps pain and perioperative pharmacists weigh a catheter-free liposomal bupivacaine block against continuous local anesthetic infusion for posterior knee pain after total knee arthroplasty.
Liposomal bupivacaine equals infusion for knee pain, but less opioid use with infusion.
Effective pain management after total knee arthroplasty (TKA) can reduce opioid use and improve recovery. Comparing continuous bupivacaine infusion and liposomal bupivacaine helps guide treatment choices. Liposomal bupivacaine was non-inferior to continuous infusion for pain relief; however, continuous infusion had lower opioid consumption and improved early rehabilitation outcomes. While liposomal bupivacaine offers comparable pain control, continuous infusion may enhance rehabilitation and reduce opioid need, despite minor catheter-related issues. Liposomal bupivacaine matches infusion for pain relief, but infusion aids recovery and reduces opioids post-TKA.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Pan X, Ye P, Xie Y, Chen Y, Fan H, Huang Y, Zheng C, Zheng X, Zheng T
Citation:Pan X, Ye P, Xie Y, et al. Analgesic Efficacy of Continuous Bupivacaine Infusion versus Liposomal Bupivacaine in Parasacral Ischial Plane Block After Total Knee Arthroplasty: An Open-Label, Randomized, Controlled, Non-Inferiority Study. Drug design, development and therapy. 2026;20:626404. doi:10.2147/DDDT.S626404